Silhouette

Woodruff Emlen

Taligen Therapeutics, Inc.

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
Monoclonal antibody to Factor B as a Therapeutic in Asthma
Taligen Therapeutics, Inc.
Principal Investigator
HHS 1 $288K 08/01/06 07/31/07
The Use of Complement Inhibitors as therapeutic agents in AMD
Taligen Therapeutics, Inc.
Principal Investigator
HHS 1 $175K 05/01/06 04/30/08
Targeted Complement Inhibitors as Therapeutic Agents
Taligen Therapeutics, Inc.
Principal Investigator
HHS 1 $179K 09/01/05 08/31/06
Monoclonal Antibody to Factor B as Therapeutic in Asthma
Taligen Therapeutics, Inc.
Principal Investigator
HHS 1 $280K 08/15/05 07/31/06
A Novel Complement Inhibitor for Rheumatoid Arthritis
Taligen Therapeutics, Inc.
Principal Investigator
HHS 1 $97.3K 04/15/05 09/30/05